Calpain 15, also referred to as SOLH (sol homologue), is a member of the calpain family of calcium-dependent cysteine proteases. Calpains play crucial roles in various cellular processes, such as cytoskeletal remodeling, cell motility, signal transduction, and protein degradation. Calpain 15 shares the structural and functional characteristics typical of calpains, including the presence of EF-hand motifs, a conserved cysteine protease domain, and regulatory domains that respond to calcium. Inhibitors targeting Calpain 15 have been the subject of interest in biochemical research due to the enzyme's involvement in intricate cellular processes. These inhibitors typically act by blocking the active site of the enzyme or by modulating the conformational states required for its calcium-dependent activation, thus preventing proteolysis of target substrates.
The design of Calpain 15 inhibitors often involves specific modifications to peptide-like scaffolds or small molecules to improve selectivity and binding affinity. Structural analysis of Calpain 15 reveals that subtle differences in the protease domain compared to other calpains can be exploited to create more selective inhibitors. This selectivity is important to avoid off-target effects on other calpains, given their widespread cellular functions. Inhibitors are typically designed to mimic the structure of the enzyme's natural substrates or transition states, effectively competing for the active site. Additionally, non-peptidic small molecules have been explored for their ability to interact with regulatory domains of the enzyme, potentially offering alternative mechanisms of inhibition. These compounds can disrupt calcium binding or interfere with domain interactions necessary for the protease's function, offering valuable insights into calpain biochemistry.
関連項目
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | ¥1343.00 ¥5043.00 | 28 | |
一种选择性钙蛋白酶抑制剂,能与酶的活性位点结合,阻碍底物的进入,从而抑制活性。 | ||||||
MDL-28170 | 88191-84-8 | sc-201301 sc-201301A sc-201301B sc-201301C | 10 mg 50 mg 100 mg 500 mg | ¥767.00 ¥2663.00 ¥4942.00 ¥24279.00 | 20 | |
一种强效的细胞渗透性钙蛋白酶抑制剂,可穿过血脑屏障,通过与蛋白酶的活性位点结合来抑制蛋白酶。 | ||||||
PD 150606 | 179528-45-1 | sc-222133 sc-222133A | 5 mg 25 mg | ¥1309.00 ¥4456.00 | 18 | |
一种抑制剂,可选择性地与钙蛋白酶上的钙结合位点结合,阻止其发生激活所需的构象变化。 | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | ¥3103.00 ¥10470.00 ¥17408.00 | 14 | |
一种不可逆的抑制剂,能共价连接到钙蛋白酶活性位点的半胱氨酸残基上,从而产生长期抑制作用。 | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | ¥812.00 ¥1636.00 ¥2990.00 ¥5517.00 ¥15784.00 ¥1117.00 | 19 | |
一种针对半胱氨酸蛋白酶活性位点硫醇基团的可逆抑制剂,从而阻碍钙蛋白酶的活性。 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | ¥632.00 ¥2933.00 ¥11056.00 | 163 | |
一种肽醛,通过与钙蛋白酶活性位点的可逆作用抑制钙蛋白酶。 | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | ¥1862.00 ¥6487.00 | 60 | |
可通过与蛋白酶体的不可逆结合间接抑制钙蛋白酶,从而减少钙蛋白酶抑制剂的降解。 | ||||||
MG-115 | 133407-86-0 | sc-221940 sc-221940A | 1 mg 5 mg | ¥982.00 ¥2482.00 | 3 | |
一种多肽醛抑制剂,可通过与钙蛋白酶的活性位点结合来阻碍其蛋白酶活性。 |